1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Opioid Settlement Funds (Connecticut State & Local) is sponsored by Connecticut Department of Mental Health and Addiction Services (DMHAS) / Opioid Settlement Advisory Committee (State) and Participating Local Governments (Local). Connecticut receives funds from opioid litigation settlements to address the opioid epidemic.
These funds are specifically meant to help address the overdose crisis, including preventing opioid use disorder, providing treatment, and reducing harm.
Get alerted about grants like this
Get emailed when new opportunities from “Connecticut Department of Mental Health and Addiction Services (DMHAS) / Opioid Settlement Advisory Committee (State) and Participating Local Governments (Local)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
CT Opioid Settlement Advisory Committee CT Opioid Settlement Advisory Committee If you are viewing this version of CT. gov, you are using an unsupported browser or you are in Internet Explorer 9 using compatibility mode. This means that the design and layout of the site is not fully supported, however the content of the site is still fully accessible and functional.
For the full website experience, please update your browser to one of the Internet Explorer 10 or higher. High Contrast Mode On or Off switch Department of Mental Health and Addiction Services CT Opioid Settlement Advisory Committee Luiza Barnat, MS, MBA, LMFT, Director of Opioid Services (860) 418-6828 | Luiza. Barnat@ct.
gov Sarah Messier-Smith, LCSW, LADC, Opioid Settlement Program Manager (959) 257-6962 | Sarah. Messier-Smith@ct. gov During the 2022 legislative session Public Act 22-48, AN ACT IMPLEMENTING THE GOVERNOR’S BUDGET RECOMMENDATIONS REGARDING THE USE OF OPIOID LITIGATION PROCEEDS was passed into law.
The Act establishes a new Advisory Committee, co-chaired by DMHAS and a representative from the municipalities, to ensure the proceeds received by the state as part of the opioid litigation settlement agreements are allocated appropriately.
The Act specifies the proceeds will be spent on substance use disorder abatement infrastructure, programs, services, supports, and resources for prevention, treatment, recovery, and harm reduction with public involvement, transparency, and accountability. Connecticut’s Opioid Settlement Funds Dashboard This interactive dashboard provides insights into opioid settlement expenditures for the State of Connecticut.
Users can explore expenditure data categorized by treatment, recovery, prevention, and harm reduction. The dashboard features a bar graph that breaks down expenditures by year. Additionally, a detailed table displays each approved project, including project status, funding amount, partners, and brief description.
Please note CT Municipal Settlement Expenditures are reported separately; annual reports are available at the bottom of this website. data last updated on 04/02/2026 Click here open the dashboard in new window.
Opioid Settlement Funding Recommendation Process If you have a recommendation for consideration for Opioid Settlement Funding, please submit an approximately 500-word description of your recommendation and an annualized budget to OSAC@ct. gov . Please note funding recommendations are not applications for funding and submissions do not guarantee that the submitter will receive funding from the Department.
We appreciate your input and will vet it through the following process: Recommendations for Opioid Settlement Funding will be sent to the Opioid Settlement Advisory Committee (OSAC) Referral Subcommittee and/or to the appropriate Alcohol and Drug Policy Council (ADPC) subcommittee for review.
If deemed to be appropriate for Opioid Settlement Funding by the subcommittees, the recommendation will be vetted and voted on by the Opioid Settlement Advisory Committee (OSAC). Please note all recommendations are considered funding suggestions, not a funding application or grant proposal. If your recommendation is approved by OSAC, it may result in a Request for Proposals, at which time you may apply for funding.
Introduction and Approval of Opioid Remediation Recommendations NEW : Opioid Settlement Public Input on Funding of Initiatives to Combat the Opioid Crisis Summary updated 3/3/26 Connecticut Opioid Settlement Fund Approved Initiatives OSAC Meetings 2026 Schedule Approved Funding Recommendation Naloxone Saturation Continuation, LiveLOUD Public Awareness and Education Continuation Data Collection and Outcome Report Overview National Recovery Month Spotlight CT's Substance Use Prevention Overview Recovery Centers Continuation, CT Drug Data Collaborative, OTP Access Expansion Emergency Department Recovery Coaching MDFT HYPE Recovery Presentation CT Drug Trends Presentation SafeSpot Overdose Hotline, Harm Reduction Centers, Supportive Housing Harm Reduction Centers in CT SafeSpot Overdose Hotline Presentation Promote and Expand Opioid Overdose Education in CT's Colleges and Universities Contingency Management Presentation Contingency Management, LiveLOUD Public Awareness and Education, Treatment Bridge Model for CT's EDs Prevention and Harm Reduction Through Public Access Modeling Interventions Presentation SSP Supplies Expansion, DOC OTP Expansion, TPP Continuation, Naloxone Saturation Final CORE Report Presentation Relative Risk of Opioid-Involved Death Following Exposure to Treatments for Opioid Use Disorder Mobile Opioid Treatment Programs (OTPs) DMHAS LiveLOUD Media Campaign Unintentional and Undetermined Intent Drug Overdose Deaths CT 2019-2022 Opioid Prevention, Education & Awareness Activities Additional OSAC Information Connecticut State Opioid Settlement Advisory Committee Bylaws Opioid Settlement Advisory Committee Public Participation Guidelines OSAC Project Data Collection and Outcome Report December 2026 Opioid Abatement Allowable Use Resources Connecticut Opioid REsponse Initiative (CORE Report) March 2024 Exhibit E: List of Opioid Remediation Uses Ad Hoc Subcommittee Meetings Governance Committee/ Bylaws Subcommittee: Finance/Compliance Subcommittee: Agendas: 2023 ; 2024 ; 2025 ; 2026 Minutes: 2023 ; 2024 ; 2025 Public Participation Guidelines Subcommittee: Research/Data Subcommittee: Agendas: 2023 ; 2024 ; 2025 ; 2026 Minutes: 2023 ; 2024 ; 2025 ; 2026 Agendas: 2023 ; 2024 ; 2025 ; 2026 Minutes: 2023 ; 2024 ; 2025 National Opioid Settlement Payments (Distributor and Janssen) - Municipalities' Share PLEASE NOTE: This public dashboard was created by the Directing Administrator of the Distributor Settlement Agreement, dated as of July 21, 2021, between and among the Settling States, the Settling Distributors, and Participating Subdivisions (the “Distributor Settlement Agreement”) and the Janssen Settlement Agreement, dated as of July 21, 2021, between and among the Settling States, Janssen, and Participating Subdivisions (the “Janssen Settlement Agreement,” and together with the Distributor Settlement Agreement, the “Settlement Agreements”).
All capitalized terms used in this dashboard have the meanings set forth in the Settlement Agreements. The calculations below are the amounts that the indicated State(s) and/or Subdivision(s) would receive pursuant to the Settlement Agreements if all relevant facts and circumstances were to remain unchanged.
Be advised, however, that the relevant facts and circumstances, including but not limited to current levels of State and Subdivision participation, are subject to change and thus, there are no guarantees regarding the amounts or timing of any future payment(s). The amounts and timing of any future payments will be governed by the terms of the Settlement Agreements.
Payment timing and amounts are subject to change and may be affected by, among other things, increased participation in a State, a State’s eligibility for Incentive Payment D, and suspensions or offsets related to Later Litigating Subdivisions. See, e.g., Section IV, Section XII, and Section XIII of the Distributor Settlement Agreement and Section V and Section IX of the Janssen Settlement Agreement.
Payment timing and amounts may also be affected by the Pre-payment Option and/or Significant Financial Constraint provisions of the Distributor Settlement Agreement (Section IV. J and Section IV. K).
Please also note that these calculations do not take into account any Settlement Fund Administrator costs and fees that exceed the available interest accrued in the Settlement Fund.
Pursuant to Public Act 23-92, Section 2: “Any municipality that receives moneys directly from a settlement administrator pursuant to a judgment, consent decree or settlement related to opioid litigation shall submit an annual report to the committee detailing its expenditures for the preceding fiscal year on a form prescribed by the committee.
Each such municipality shall submit such report to the committee on or before October 1, 2023, and annually thereafter, until the total amount of such moneys received by the municipality has been expended. ” Please see below for completed reports.
Connecticut Opioid Municipal Settlement Proceeds Report (PA 23-92) Fiscal Year 2025 Connecticut Opioid Municipal Settlement Proceeds Report (PA 23-92) Fiscal Year 2024 Connecticut Opioid Municipal Settlement Proceeds Report (PA 23-92) Fiscal Year 2023 Municipal Briefing November 2025 Municipal Briefing August 2025
According to the current listing, eligibility includes: Eligible entities vary by specific initiative. State funds are disbursed by DMHAS for statewide programs. Confirm the full requirements in the official notice before applying.
The current listing shows varies by specific initiative (Connecticut is expected to receive approximately $600 million total from settlements). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Opioid Settlement Funds (Connecticut State & Local) is funded by Connecticut Department of Mental Health and Addiction Services (DMHAS) / Opioid Settlement Advisory Committee (State) and Participating Local Governments (Local). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Connecticut. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
HHS launched the STREETS Initiative and SAMHSA announced $69M in mental health grants as part of the Great American Recovery. A deep analysis of eligibility, strategy, and what organizations should apply.
Read articleSAMHSA's June 11 release of eight FY26 grant programs ranges from $600K to $9.2M and lands under the Trump-Kennedy-Burgum Great American Recovery Initiative. The SBIRT NOFO's 30-application cap means the deadline is functionally first-come, first-served.
Read articlePMHCA (HRSA-26-058) makes $9.79 million available for up to 22 awards of up to $445,000 to build tele-consultation networks that help pediatric primary care providers manage children's behavioral health. The catch buried in the eligibility section: applicants must NOT already hold a PMHCA award — which effectively reserves the new-state lane for the eight unfunded states and territories, plus tribes everywhere. Here's how to read it and what wins.
Read article